mucobromic acid: in Chemline, RN above is for the gamma-lactone form; asparagine synthetase antagonist; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3033972 |
| SCHEMBL ID | 319076 |
| MeSH ID | M0062389 |
| Synonym |
|---|
| c4h2br2o3 |
| 2-butenoic acid, 2,3-dibromo-4-oxo-, (z)- |
| 2-butenoic acid,3-dibromo-4-oxo-, (z)- |
| nsc12426 |
| 488-11-9 |
| nsc-12426 |
| malealdehydic acid, dibromo- |
| mucobromic acid |
| bromomucic acid |
| mucobromic acid, 99% |
| ai3-16061 |
| nsc 12426 |
| ccris 6704 |
| 2-butenoic acid, 2,3-dibromo-4-oxo-, (2z)- |
| einecs 207-670-5 |
| (z)-2,3-dibromo-4-oxobut-2-enoic acid |
| M0471 |
| AKOS003625055 |
| A827609 |
| (z)-2,3-dibromo-4-oxo-but-2-enoic acid |
| A815495 |
| 2,3-dibromo-4-oxo-2-butenoic acid |
| (2z)-2,3-dibromo-4-oxobut-2-enoic acid |
| BP-10120 |
| mucobromicacid |
| SCHEMBL319076 |
| mucobromic acid;2,3-dibromo-4-oxo-2-butenoic acid |
| 2-butenoic acid, 2,3-dibromo-4-oxo- |
| W-106039 |
| J-610084 |
| (2z)-2,3-dibromo-4-oxo-2-butenoic acid |
| mfcd00063745 |
| F2191-0142 |
| STL194197 |
| D78114 |
| DTXSID20883397 |
| mucobromic acid 2,3-dibromo-4-oxo-2-butenoic acid |
| (z)-2,3-dibromo-4-oxobut-2-enoicacid |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||